Shanghai Pharmaceuticals Holding SHPMF Stock
Shanghai Pharmaceuticals Holding Price Chart
Shanghai Pharmaceuticals Holding SHPMF Financial and Trading Overview
| Shanghai Pharmaceuticals Holding stock price | 1.56 USD |
| Previous Close | 1.97 USD |
| Open | 1.92 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.97 - 1.97 USD |
| 52 Week Range | 1.28 - 2.08 USD |
| Volume | 21.6K USD |
| Avg. Volume | 860 USD |
| Market Cap | 10.44B USD |
| Beta (5Y Monthly) | 0.320547 |
| PE Ratio (TTM) | 8.954546 |
| EPS (TTM) | 0.17 USD |
| Forward Dividend & Yield | 0.06 (3.18%) |
| Ex-Dividend Date | July 20, 2022 |
| 1y Target Est | N/A |
SHPMF Valuation Measures
| Enterprise Value | 31.15B USD |
| Trailing P/E | 8.954546 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.043247584 |
| Price/Book (mrq) | 0.106262475 |
| Enterprise Value/Revenue | 0.129 |
| Enterprise Value/EBITDA | 3.129 |
Trading Information
Shanghai Pharmaceuticals Holding Stock Price History
| Beta (5Y Monthly) | 0.320547 |
| 52-Week Change | 24.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.08 USD |
| 52 Week Low | 1.28 USD |
| 50-Day Moving Average | 1.95 USD |
| 200-Day Moving Average | 1.71 USD |
SHPMF Share Statistics
| Avg. Volume (3 month) | 860 USD |
| Avg. Daily Volume (10-Days) | 2.66K USD |
| Shares Outstanding | 919.07M |
| Float | 1.64B |
| Short Ratio | N/A |
| % Held by Insiders | 22.00% |
| % Held by Institutions | 31.06% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.61 |
| Trailing Annual Dividend Yield | 30.96% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2681 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.43% |
| Operating Margin (ttm) | 3.57% |
| Gross Margin | 13.12% |
| EBITDA Margin | 4.12% |
Management Effectiveness
| Return on Assets (ttm) | 2.78% |
| Return on Equity (ttm) | 9.61% |
Income Statement
| Revenue (ttm) | 241.31B USD |
| Revenue Per Share (ttm) | 65.27 USD |
| Quarterly Revenue Growth (yoy) | 16.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | 9.96B USD |
| Net Income Avi to Common (ttm) | 5.88B USD |
| Diluted EPS (ttm) | 0.22 |
| Quarterly Earnings Growth (yoy) | 21.30% |
Balance Sheet
| Total Cash (mrq) | 38.11B USD |
| Total Cash Per Share (mrq) | 10.3 USD |
| Total Debt (mrq) | 50.66B USD |
| Total Debt/Equity (mrq) | 63.42 USD |
| Current Ratio (mrq) | 1.375 |
| Book Value Per Share (mrq) | 18.539 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.61B USD |
| Levered Free Cash Flow (ttm) | -1122903680 USD |
Profile of Shanghai Pharmaceuticals Holding
| Country | United States |
| State | N/A |
| City | Shanghai |
| Address | Shanghai Pharmaceutical Building |
| ZIP | 200020 |
| Phone | 86 21 6373 0908 |
| Website | https://www.sphchina.com |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 47877 |
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Q&A For Shanghai Pharmaceuticals Holding Stock
What is a current SHPMF stock price?
Shanghai Pharmaceuticals Holding SHPMF stock price today per share is 1.56 USD.
How to purchase Shanghai Pharmaceuticals Holding stock?
You can buy SHPMF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Pharmaceuticals Holding?
The stock symbol or ticker of Shanghai Pharmaceuticals Holding is SHPMF.
Which industry does the Shanghai Pharmaceuticals Holding company belong to?
The Shanghai Pharmaceuticals Holding industry is Medical Distribution.
How many shares does Shanghai Pharmaceuticals Holding have in circulation?
The max supply of Shanghai Pharmaceuticals Holding shares is 5.3B.
What is Shanghai Pharmaceuticals Holding Price to Earnings Ratio (PE Ratio)?
Shanghai Pharmaceuticals Holding PE Ratio is 9.18823500 now.
What was Shanghai Pharmaceuticals Holding earnings per share over the trailing 12 months (TTM)?
Shanghai Pharmaceuticals Holding EPS is 0.17 USD over the trailing 12 months.
Which sector does the Shanghai Pharmaceuticals Holding company belong to?
The Shanghai Pharmaceuticals Holding sector is Healthcare.